C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/1999
12/21/1999	US6004535 Methods of imaging neoplastic disease and of detecting and quantifying MN protein/polypeptide using MN-specific antibodies
12/21/1999	CA2122135C Recombinant core-streptavidin
12/21/1999	CA2072891C Pseudomonas exotoxin fusion proteins having carboxyl alterations with increased cytotoxicity
12/21/1999	CA2065287C New hcv isolates
12/21/1999	CA2058872C Recombinant iga protease
12/21/1999	CA1340858C Recombinant and native group b eimeria tenella immunogens useful as coccidiosis vaccines
12/21/1999	CA1340857C Synthetic plasmid transformant, feline interferon gene and method for producing feline interferon
12/21/1999	CA1340855C Neurite-promoting factor and process for the manufacture thereof
12/21/1999	CA1340853C Purification of recombinant interleukin-2
12/16/1999	WO1999064865A1 Assays for tsh receptor autoantibodies
12/16/1999	WO1999064633A1 Herpes simplex virus origin binding protein n-terminal truncation (obp-nt)
12/16/1999	WO1999064629A1 Acrp30r2, a homolog of acrp30 (30 kd adipocyte complement-related protein)
12/16/1999	WO1999064611A1 Mass production method of antimicrobial peptide and dna construct and expression system thereof
12/16/1999	WO1999064607A1 Industrial method for producing heterologous proteins in e.coli and strains useful for said method
12/16/1999	WO1999064598A2 Novel insulin analogs with enhanced zinc binding
12/16/1999	WO1999064593A2 Cell cycle regulation proteins
12/16/1999	WO1999064591A1 Antibody against lar phosphatase subunit
12/16/1999	WO1999064585A2 Novel angiotensin receptor, production and use thereof
12/16/1999	WO1999064584A2 Protein for regulating apoptosis
12/16/1999	WO1999064463A1 Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples
12/16/1999	WO1999064461A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same
12/16/1999	WO1999064455A1 Peptides having nuclear transport activity
12/16/1999	WO1999064454A1 Novel nucleolar protein
12/16/1999	WO1999064452A1 Gpr35a receptor
12/16/1999	WO1999064441A1 Method for preparing virus-safe pharmaceutical compositions
12/16/1999	WO1999064435A1 The human kidney specific gene kk86
12/16/1999	WO1999064067A2 Vaccine
12/16/1999	WO1999064021A1 hCEPR RECEPTOR
12/16/1999	WO1999057292A9 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery
12/16/1999	WO1999055899A9 Methods for transducing fusion molecules
12/16/1999	WO1999054467A9 Sh2 domain-containing peptides
12/16/1999	WO1999052947A3 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA)
12/16/1999	WO1999046380A3 Human membrane spanning proteins
12/16/1999	WO1999045107A8 Novel calpain and dna encoding the same
12/16/1999	WO1999043807A3 Human channel-related molecules
12/16/1999	WO1999041375A3 Human receptor proteins
12/16/1999	WO1999041373A3 Human transport-associated molecules
12/16/1999	CA2331150A1 Industrial method for producing heterologous proteins in e.coli and strains useful for said method
12/16/1999	CA2330548A1 Peptides having nuclear transport activity
12/16/1999	CA2330238A1 Vaccine
12/16/1999	CA2330230A1 Herpes simplex virus origin binding protein n-terminal truncation (obp-nt)
12/16/1999	CA2330229A1 Novel angiotensin receptor, production and use thereof
12/16/1999	CA2330168A1 Protein for regulating apoptosis
12/16/1999	CA2329688A1 Cell cycle regulation proteins
12/16/1999	CA2328498A1 Monoclonal antibodies, cross-reactive antibodies and method for producing the same____________________________________
12/15/1999	EP0963438A1 RECOMBINANT P37/FlaA AS A DIAGNOSTIC REAGENT
12/15/1999	EP0963436A1 Nucleic acid encoding congenital heart disease protein and products related thereto
12/15/1999	EP0963435A1 Methods for production of proteins
12/15/1999	EP0963432A1 Kuz, a novel family of metalloproteases
12/15/1999	EP0963377A1 Interleukin-19
12/15/1999	EP0963205A1 T1 receptor-like ligand ii
12/15/1999	EP0668912B1 THE St-B17 SEROTONIN RECEPTOR
12/15/1999	EP0567567B1 A RECEPTOR TYROSINE KINASE TARGET PROTEIN cDNA CLONING METHOD AND hGRB PROTEINS
12/15/1999	CN1238778A Method for determining expression of aberrant forms of APC protein
12/15/1999	CN1047402C Process for producing synthetic gene of encoding polyporus seed storage albumen
12/14/1999	US6001977 Antibody produced by immunizing an animal with an immunoreactive polypeptide from the envelope domain of human immunodeficiency virus; for diagnostic immunoassays and neutralizing antibodies
12/14/1999	US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor
12/14/1999	US6001970 Modified human neuropeptide Y1 Receptors
12/14/1999	US6001802 Antiproliferative agents
12/14/1999	US6001649 Chemokine NC28 (monocyte chemotactic protein-3, MCP-3) polypeptides and their recombinant production
12/14/1999	US6001623 Polynucleotide sequence coding a human enzymatic polypeptide; for developing treatments and diagnostic assays for disease
12/14/1999	US6001605 Dna sequence coding for two cytokines; diagnosing human colon cancer; for detecting antiinflammatory agents
12/14/1999	US6001602 DNA encoding Chlamydia trachomatis isoleucyl tRNA synthetase polypeptides
12/14/1999	US6001601 Methionyl tRNA synthetase polynucleotides
12/14/1999	US6001594 Human testin
12/14/1999	US6001581 Cation-based bioassay using human metabotropic glutamate receptors
12/14/1999	US6001560 Stably-transformed human cell lines containing a human gamma interferon-responsive human hla-dr alpha promoter operatively linked to a reporter gene for use in screening for agonists or antagonists of human gamma interferon
12/14/1999	US6001363 Eimeria protein with immunogenic properties; dna encoding this protein can be used for the preparation of a vector vaccine against coccidiosis
12/14/1999	US6001361 For the prevention, treatment and diagnosis of mycobacterial infection, together with adjuvants for use in vaccines or immunotherapy of infectious diseases and cancers; for preventing, treating and detecting tuberculosis
12/14/1999	CA2181150C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
12/14/1999	CA2172137C Surface loop structural analogues of fibroblast growth factors
12/14/1999	CA2155024C Genetic modification of neural stem cells
12/14/1999	CA2135642C Tat-derived transport polypeptides
12/14/1999	CA2117795C Gustducin materials and methods
12/14/1999	CA2095642C Adhesion receptors for pathogenic or opportunistic microorganisms
12/14/1999	CA2092720C Macrophage activating factor from vitamin d binding protein
12/14/1999	CA2089161C Separation of proteins and dyes
12/14/1999	CA2084186C Purification of human interleukin-4 secreted from a escherichia coli mutant
12/14/1999	CA2081028C Cd2 binding domain of lymphocyte function associated antigen 3
12/14/1999	CA2036913C A modified transcription control unit and uses thereof
12/14/1999	CA1340852C Process for purifying primate gm-csf protein
12/14/1999	CA1340848C Pseudorabies virus protein
12/14/1999	CA1340847C Adhesin antigens
12/12/1999	CA2272599A1 Rice gene resistant to blast disease
12/09/1999	WO1999063106A1 Biotechnological production of polyglutaminic acid
12/09/1999	WO1999063090A2 Protease inhibitor peptides
12/09/1999	WO1999063089A1 Cyclin e2 genes and proteins
12/09/1999	WO1999063087A1 G-protein coupled receptor, named 2871 receptor
12/09/1999	WO1999063083A1 Novel gene and protein encoded thereby
12/09/1999	WO1999063075A1 Monoclonal antibodies and method for assaying fdp
12/09/1999	WO1999063058A1 Media for culturing animal cells and process for producing protein by using the same
12/09/1999	WO1999062942A2 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
12/09/1999	WO1999062941A2 Serpentine transmembrane antigens expressed in human cancers and uses thereof
12/09/1999	WO1999062939A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
12/09/1999	WO1999062937A1 Purification of antibodies
12/09/1999	WO1999062549A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases
12/09/1999	WO1999062547A1 HUMAN MINOR VAULT PROTEIN p193
12/09/1999	WO1999062527A1 nrdE
12/09/1999	WO1999062526A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
12/09/1999	WO1999052938A3 Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites

1 ... 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 ... 1125